title: Insulin-like growth factor-induced signals activate mitochondrial respiration.
abstract: From experiments with lower eukaryotes it is known that the metabolic rate and also the rate of aging are tightly controlled by the insulin-like growth factor (IGF)/insulin signal transduction pathway. The mitochondrial theory of aging implies that an increased metabolic rate leads to increased mitochondrial activity; increased production of reactive oxygen species due to these alterations would speed up the aging process. To address the question if mitochondrial activity is influenced by insulin/IGF signaling, we have established an experimental system to determine the influence of IGF-I-dependent signaling on mitochondrial function. We used DU145 prostate cancer cells, known for the intact IGF signal transduction pathway, to address the influence of IGF receptor activation on mitochondrial function by high-resolution respirometry. These experiments revealed that indeed mitochondrial function is regulated by IGF signaling, and up-regulation of respiration seems to require phosphoinositide 3-kinase/AKT signaling, but is independent of IGF effects on cell cycle progression. Collectively these data establish a regulatory cross-talk between insulin/IGF signal transduction and mitochondrial function, two major pathways implicated in controlling the rate of aging.
authors.affiliation: Institute for Biomedical Aging Research, Austrian Academy of Sciences, Innsbruck, Austria.
authors.forename: Hermann
authors.initials: H
authors.lastname: Unterluggauer
authors.forename: Eveline
authors.initials: E
authors.lastname: Hütter
authors.forename: Hans-Peter
authors.initials: HP
authors.lastname: Viertler
authors.forename: Pidder
authors.initials: P
authors.lastname: Jansen-Dürr
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D019069:Cell Respiration / Q000187:drug effects*; D008297:Male; D008928:Mitochondria / Q000187:drug effects*; D011471:Prostatic Neoplasms / Q000503:physiopathology*; D015398:Signal Transduction / Q000187:drug effects*; D013002:Somatomedins / Q000008:administration & dosage*
chemical_list: D013002:Somatomedins